|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety and efficacy of the specific endothelin A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic:a doubleblind,placebo-controlled,randomized,Phase Ⅱ trial显示文摘 | JAMES ND CATY A BORRE M | 2009 | Eur Urol2009，55，： | 1 |
| 2 | The syetemic treatment of advanced and metastatic bladder cancer显示文摘 | Hussain SA James ND | 2003 | Lancet Oncol2003，4，8： | 1 |
| 3 | The changing pattern of management for hormone-refractory, metastatic prostate cancer 显示文摘 | James ND Bloomfield D Luscombe C | 2006 | Prostate Cancer Prostatic Dis2006，9，： | 1 |
| 4 | The systemic treatment of advanced and metastatic bladder cancer显示文摘 | Hussain SA James ND | 2003 | Lancet Oncol2003，4，： | 1 |
| 5 | CD40 expression in bladder cancer显示文摘 | Cooke PW James ND Ganesan R | 1999 | Pathol1999，188，1： | 1 |
| 6 | The systemic treatment of advanced and metastatic bladder cancer显示文摘 | HUSSAIN SA JAMES ND | 2003 | Lancet Oncol2003，4，8： | 1 |
| 7 | Radiotherapy with or without chemotherapy in muscle - invasive bladder cancer 显示文摘 | James ND Hussain SA Hall E | 2012 | New England Journal of Medicine2012，366，16： | 1 |
| 8 | Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone- resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, random- ised,phase 2 trial显示文摘 | James ND Caty A Borre M | 2009 | Eur Urol2009，55，5： | 1 |
| 9 | Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer显示文摘 | James ND Hussain SA Hall E | 2012 | New England Journal of Medicine2012，366，16： | 1 |
| 10 | Signal transduction thera-py:challenges to clinical trial design显示文摘 | Hussain SA Rea DW James ND | 2007 | Current Signal Trans-duction Therapy2007，2，： | 1 |
| 11 | Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic:A double-blind,placebo-controlled,randomised,phase 2 trial显示文摘 | James ND Caty A Borre M | 2009 | Eur Urol2009，55，： | 1 |
| 12 | Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer:the MRC STAMPEDE trial显示文摘 | Sydes MR Parmar MK James ND | 2009 | Trials2009，10，： | 1 |
| 13 | Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis显示文摘 | VAN ROEKEL EH CHENG KK JAMES ND | 2013 | Int J Cancer2013，133，2： | 1 |
| 14 | Naloxone aclministration to patients with acutestroke 显示文摘 | Jaboviy James ND | 1954 | Stroke1954，15，1： | 1 |
| 15 | The systemic treatment of advanced and metastatic bladder cancer显示文摘 | Hussain SA James ND | 2003 | Lancet Oncology2003，，08： | 1 |
| 16 | Results of a phase III randomized trial of synchronous chemoradiotherapy (CRT) compared to radiotherapy (RT) alone in muscle-in- vasive bladder cancer (MIBC) (BC2001 CRUKJ01/004) 显示文摘 | James ND Hussain SA Hall E | 2010 | J Clin Oncol2010，28，15： | 1 |
| 17 | Failure - Free Surviv- al and Radiotherapy in Patients With Newly Diagnosed Nonmeta- static Prostate Cancer: Data From Patients in the Contrel Arm of the STAMPEDE Trial显示文摘 | James ND Spears MR Clarke NW | 2015 | JAMA Oncol2015，，： | 1 |
| 18 | Radiotherapy with or without chemotherapy in muscle-invasive bladder can- cer显示文摘 | James ND Hussain SA Hall E | 2012 | N Engl J Med2012，366，16： | 1 |
| 19 | Biomarkers in bladder cancer 显示文摘 | Bryan RT Zeegers MP James ND | 2010 | BJU Int2010，105，5： | 1 |
| 20 | Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer显示文摘 | Tannock IF de Wit R Berry WR Horti J Pluzanska A Chi KN Oudard S Theodore C James ND Turesson I Rosenthal MA Eisenberger MA TAX 327 Investigators | 2004 | N Engl J Med2004，351，15： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员